Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.175
-0.155 (-6.65%)
Nov 4, 2025, 2:52 PM EST - Market open
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $68.42 million as of November 4, 2025. Its market cap has decreased by -71.93% in one year.
Market Cap
68.42M
Enterprise Value
-65.59M
1-Year Change
-71.93%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $68.42M, a decrease of -70.90%. That is a compound annual growth rate of -34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 73.29M | -60.90% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |